146 filings
Page 7 of 8
8-K/A
xtsmypl8m
25 Mar 15
Financial Statements and Exhibits
12:00am
8-K
b4pyvp
25 Mar 15
Other Events
12:00am
8-K
szqla5
23 Mar 15
Other Events
12:00am
8-K
dueayd27xndhzobd6 jh
18 Mar 15
Other Events
12:00am
8-K
msb65hv2xrrjb3i6vqu
16 Mar 15
Egalet Reports Full Year 2014 Financial Results
12:00am
8-K
6c2m53d75u e507c
11 Mar 15
Egalet Accelerates Development of Abuse-Deterrent Morphine Egalet-001 and Plans to File New Drug Application in the Fourth Quarter
12:00am
8-K
yks3bbu qmi
12 Feb 15
Other Events
12:00am
8-K
hkk5p9vzf8g
22 Jan 15
Egalet Announces Positive Top-Line Results from Oral Human Abuse Liability Study of Abuse-Deterrent Morphine, Egalet-001
12:00am
8-K
2fo5xdw9eojkjiggf
13 Jan 15
Egalet Acquires/Licenses Two Innovative Approved Pain Products
12:00am
8-K
xozbrmijfdsa0u2g7n2
12 Jan 15
Egalet Appoints Deanne F. Melloy as Chief Commercial Officer
12:00am
8-K
vm6k613c jlcc9wpc
12 Nov 14
Egalet Reports Third Quarter 2014 Financial Results and Provides Business Update
12:00am
8-K
lat xcgz3klhf9mj36
24 Sep 14
Egalet Announces Update on Clinical Development Plan for Abuse-Deterrent Morphine Egalet-001
12:00am
8-K
zhwx s7e3pc
4 Sep 14
Egalet to Present Data from Abuse-Deterrence Studies at PainWeek 2014 in Las Vegas
12:00am
8-K
23i 0qkaid
18 Aug 14
Egalet Announces Successful End-of-Phase 2 Meeting with the FDA for Egalet-002
12:00am
8-K
v9p2p62of
14 Aug 14
Regulation FD Disclosure
12:00am
8-K
h0p9yyxm mj
12 Aug 14
Egalet Reports Second Quarter 2014 Financial Results and Provides Business Update
12:00am
8-K
mhl3up zp
6 Aug 14
Egalet Announces Topline Results from Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-001
12:00am
8-K
x9v6pztmh0ydg6
28 Jul 14
Egalet Appoints Jeffrey M. Dayno, M.D. as Chief Medical Officer
12:00am
8-K
jsfukyn
15 Jul 14
Egalet Reports Positive Top-Line Results from Category 1 Abuse Deterrence Studies Demonstrating Egalet-001 Resists Physical and Chemical Manipulation
12:00am
8-K
dpcyqd4wof181
10 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am